Your browser doesn't support javascript.
loading
Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins.
Bertolesi, G E; Lauría de Cidre, L; Eiján, A M.
Afiliación
  • Bertolesi GE; Area de Investigaciones, Instituto de Oncología A.H. Roffo, Universidad de Buenos Aires, Argentina.
Tumour Biol ; 15(5): 275-83, 1994.
Article en En | MEDLINE | ID: mdl-7991988
ABSTRACT
Heparin, a highly sulfated polysaccharide used as an antithrombotic and anticoagulant, inhibits proliferation of several cell types. We have investigated the effect of heparin and chemically modified heparins on the growth of a cell culture of a murine mammary adenocarcinoma (M3). We found that heparin inhibited the proliferation of M3 cells growing either with or without 2% fetal calf serum (FCS) in a dose-dependent and reversible fashion. Several heparins with different anticoagulant properties showed a similar antiproliferative effect. Histological assays showed that heparin was internalized and appeared in cytoplasmic vesicules. O-desulfated, O/N-desulfated N-acetylated and N-desulfated heparins lost their antiproliferative activity, while N-desulfated N-acetylated heparin significantly inhibited cell proliferation with or without FCS. The finding of an antiproliferative action of N-desulfated N-acetylated heparin which does not show anticoagulant activity suggests a possible therapeutic role for this compound as an antineoplastic drug.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Heparina / Adenocarcinoma / Neoplasias Mamarias Experimentales Límite: Animals Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 1994 Tipo del documento: Article País de afiliación: Argentina
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Heparina / Adenocarcinoma / Neoplasias Mamarias Experimentales Límite: Animals Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 1994 Tipo del documento: Article País de afiliación: Argentina